Course Directors: Matthew A. Romano, Ann Arbor, MI, and Edward G. Soltesz, Cleveland, OH
COMMERCIAL RELATIONSHIPS M.A. Romano− Consultant/Advisory Board: Edwards Lifesciences Corporation; Research Grant: Edwards Lifesciences Corporation, AtriCure, Inc; E.G. Soltesz− Speakers Bureau/Honoraria: St. Jude Medical, Edwards Lifesciences Corporation, AtriCure, Inc
Atrial fibrillation is often encountered by cardiac surgeons in patients referred for other cardiac surgical procedures. However, surgical ablation of atrial fibrillation continues to be undertreated at the time of cardiac surgery. Recent data has supported high rates of sinus rhythm restoration and a survival advantage for concomitant treatment of atrial fibrillation during cardiac surgery. Unfamiliarity with recommended lesion sets, energy sources, available devices and techniques has resulted in an underutilization of the Maze procedure.
Upon completion of this activity, participants should be able to:
- Explain the different energy sources for performing the Maze procedure and their appropriate applications
- Perform the Maze IV procedure lesions based on different operative scenarios (mitral valve surgery, CABG, AVR)
- Explain the technical aspects of a minimally invasive MAZE procedure.
Please watch the video below containing background information and lecture materials associated with this course.
Please note: No CME credit is associated with the viewing of web-based content. This presentation was created for The Society of Thoracic Surgeons STS University courses, and STS retains sole rights to these materials.